ArticleScientific reports2022

Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications.

H Al TbeishatPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.